Neurostimulation Devices Market (By Technology: Aneurysm coiling & embolization devices, Cerebral balloon angioplasty & Stenting systems, Support devices, Neurothrombectomy devices; By Disease Pathology: Ischemic Strokes, Cerebral Aneuryms, Carotid Artery Stenosis, Arteriovenous Malformations and Fistulas, Other Diseases; By Product; By Application; By End Users) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Neurostimulation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Neurostimulation Devices Market, by January, 2024-2033
8.1.1. Aneurysm coiling & embolization devices
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Cerebral balloon angioplasty & Stenting systems
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Support devices
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Neurothrombectomy devices
8.1.4.1. Market Revenue and Forecast (2021-2033)
9.1. Neurostimulation Devices Market, by February, 2024-2033
9.1.1. Ischemic Strokes
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Cerebral Aneuryms
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Carotid Artery Stenosis
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Arteriovenous Malformations and Fistulas
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Other Diseases
9.1.5.1. Market Revenue and Forecast (2021-2033)
10.1. Neurostimulation Devices Market, by March, 2024-2033
10.1.1. Spinal Cord Stimulator
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Deep Brain Stimulator
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Sacral Nerve Stimulator
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Vagus Nerve Stimulator
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Gastric Electric Stimulator
10.1.5.1. Market Revenue and Forecast (2021-2033)
11.1. Neurostimulation Devices Market, by April, 2024-2033
11.1.1. Pain Management
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Epilepsy
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Essential Tremor
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Urinary and Fecal Incontinence
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Depression
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Dystonia
11.1.6.1. Market Revenue and Forecast (2021-2033)
11.1.7. Gastroparesis
11.1.7.1. Market Revenue and Forecast (2021-2033)
11.1.8. Parkinson’s Disease
11.1.8.1. Market Revenue and Forecast (2021-2033)
11.1.9. Others
11.1.9.1. Market Revenue and Forecast (2021-2033)
12.1. Neurostimulation Devices Market, by May, 2024-2033
12.1.1. Hospitals & Surgical Centers
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Ambulatory Care Centers
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Research Laboratories & Academic Institutes
12.1.3.1. Market Revenue and Forecast (2021-2033)
13.1. North America
13.1.1. Market Revenue and Forecast, by January (2021-2033)
13.1.2. Market Revenue and Forecast, by February (2021-2033)
13.1.3. Market Revenue and Forecast, by March (2021-2033)
13.1.4. Market Revenue and Forecast, by April (2021-2033)
13.1.5. Market Revenue and Forecast, by May (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by January (2021-2033)
13.1.6.2. Market Revenue and Forecast, by February (2021-2033)
13.1.6.3. Market Revenue and Forecast, by March (2021-2033)
13.1.6.4. Market Revenue and Forecast, by April (2021-2033)
13.1.7. Market Revenue and Forecast, by May (2021-2033)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by January (2021-2033)
13.1.8.2. Market Revenue and Forecast, by February (2021-2033)
13.1.8.3. Market Revenue and Forecast, by March (2021-2033)
13.1.8.4. Market Revenue and Forecast, by April (2021-2033)
13.1.8.5. Market Revenue and Forecast, by May (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by January (2021-2033)
13.2.2. Market Revenue and Forecast, by February (2021-2033)
13.2.3. Market Revenue and Forecast, by March (2021-2033)
13.2.4. Market Revenue and Forecast, by April (2021-2033)
13.2.5. Market Revenue and Forecast, by May (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by January (2021-2033)
13.2.6.2. Market Revenue and Forecast, by February (2021-2033)
13.2.6.3. Market Revenue and Forecast, by March (2021-2033)
13.2.7. Market Revenue and Forecast, by April (2021-2033)
13.2.8. Market Revenue and Forecast, by May (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by January (2021-2033)
13.2.9.2. Market Revenue and Forecast, by February (2021-2033)
13.2.9.3. Market Revenue and Forecast, by March (2021-2033)
13.2.10. Market Revenue and Forecast, by April (2021-2033)
13.2.11. Market Revenue and Forecast, by May (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by January (2021-2033)
13.2.12.2. Market Revenue and Forecast, by February (2021-2033)
13.2.12.3. Market Revenue and Forecast, by March (2021-2033)
13.2.12.4. Market Revenue and Forecast, by April (2021-2033)
13.2.13. Market Revenue and Forecast, by May (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by January (2021-2033)
13.2.14.2. Market Revenue and Forecast, by February (2021-2033)
13.2.14.3. Market Revenue and Forecast, by March (2021-2033)
13.2.14.4. Market Revenue and Forecast, by April (2021-2033)
13.2.15. Market Revenue and Forecast, by May (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by January (2021-2033)
13.3.2. Market Revenue and Forecast, by February (2021-2033)
13.3.3. Market Revenue and Forecast, by March (2021-2033)
13.3.4. Market Revenue and Forecast, by April (2021-2033)
13.3.5. Market Revenue and Forecast, by May (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by January (2021-2033)
13.3.6.2. Market Revenue and Forecast, by February (2021-2033)
13.3.6.3. Market Revenue and Forecast, by March (2021-2033)
13.3.6.4. Market Revenue and Forecast, by April (2021-2033)
13.3.7. Market Revenue and Forecast, by May (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by January (2021-2033)
13.3.8.2. Market Revenue and Forecast, by February (2021-2033)
13.3.8.3. Market Revenue and Forecast, by March (2021-2033)
13.3.8.4. Market Revenue and Forecast, by April (2021-2033)
13.3.9. Market Revenue and Forecast, by May (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by January (2021-2033)
13.3.10.2. Market Revenue and Forecast, by February (2021-2033)
13.3.10.3. Market Revenue and Forecast, by March (2021-2033)
13.3.10.4. Market Revenue and Forecast, by April (2021-2033)
13.3.10.5. Market Revenue and Forecast, by May (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by January (2021-2033)
13.3.11.2. Market Revenue and Forecast, by February (2021-2033)
13.3.11.3. Market Revenue and Forecast, by March (2021-2033)
13.3.11.4. Market Revenue and Forecast, by April (2021-2033)
13.3.11.5. Market Revenue and Forecast, by May (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by January (2021-2033)
13.4.2. Market Revenue and Forecast, by February (2021-2033)
13.4.3. Market Revenue and Forecast, by March (2021-2033)
13.4.4. Market Revenue and Forecast, by April (2021-2033)
13.4.5. Market Revenue and Forecast, by May (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by January (2021-2033)
13.4.6.2. Market Revenue and Forecast, by February (2021-2033)
13.4.6.3. Market Revenue and Forecast, by March (2021-2033)
13.4.6.4. Market Revenue and Forecast, by April (2021-2033)
13.4.7. Market Revenue and Forecast, by May (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by January (2021-2033)
13.4.8.2. Market Revenue and Forecast, by February (2021-2033)
13.4.8.3. Market Revenue and Forecast, by March (2021-2033)
13.4.8.4. Market Revenue and Forecast, by April (2021-2033)
13.4.9. Market Revenue and Forecast, by May (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by January (2021-2033)
13.4.10.2. Market Revenue and Forecast, by February (2021-2033)
13.4.10.3. Market Revenue and Forecast, by March (2021-2033)
13.4.10.4. Market Revenue and Forecast, by April (2021-2033)
13.4.10.5. Market Revenue and Forecast, by May (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by January (2021-2033)
13.4.11.2. Market Revenue and Forecast, by February (2021-2033)
13.4.11.3. Market Revenue and Forecast, by March (2021-2033)
13.4.11.4. Market Revenue and Forecast, by April (2021-2033)
13.4.11.5. Market Revenue and Forecast, by May (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by January (2021-2033)
13.5.2. Market Revenue and Forecast, by February (2021-2033)
13.5.3. Market Revenue and Forecast, by March (2021-2033)
13.5.4. Market Revenue and Forecast, by April (2021-2033)
13.5.5. Market Revenue and Forecast, by May (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by January (2021-2033)
13.5.6.2. Market Revenue and Forecast, by February (2021-2033)
13.5.6.3. Market Revenue and Forecast, by March (2021-2033)
13.5.6.4. Market Revenue and Forecast, by April (2021-2033)
13.5.7. Market Revenue and Forecast, by May (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by January (2021-2033)
13.5.8.2. Market Revenue and Forecast, by February (2021-2033)
13.5.8.3. Market Revenue and Forecast, by March (2021-2033)
13.5.8.4. Market Revenue and Forecast, by April (2021-2033)
13.5.8.5. Market Revenue and Forecast, by May (2021-2033)
14.1. Medtronic PLC
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cyberonics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Boston Scientific Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. St. Jude Medical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Nevro Corp.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. MicroPort Scientific Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kaneka Corp
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Integer Holdings Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BALT
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Perflow Medical
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client